series-a
Stage
1
Investors
About
ProteinQure is a clinical-stage biotech company that uses a proprietary AI-based computational platform to design novel peptide-drug conjugates for tissue- and cell-specific delivery of therapeutics, focusing on precision medicine applications in oncology and other diseases.
Explore ProteinQure's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.